AB SCIENCE SA (ABSCF:OTCMKTS)
$0 None (None%)
Analysed AB SCIENCE SA (ABSCF:OTCMKTS) News Sources
AB Science receives notice of allowance for US patent covering masitinib in the treatment of metastatic castrate resistant prostate cancer
29-01-2026
yahoo.com
AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet® in the treatment of canine mast cell tumors
09-02-2026
yahoo.com
Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
19-02-2026
yahoo.com
What is the current price of AB SCIENCE SA (ABSCF:OTCMKTS)?
The current price of AB SCIENCE SA (ABSCF:OTCMKTS) is $0.
AB SCIENCE SA (ABSCF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of AB SCIENCE SA (ABSCF:OTCMKTS) since the previous trading day is $None.
AB SCIENCE SA (ABSCF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of AB SCIENCE SA (ABSCF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for AB SCIENCE SA (ABSCF:OTCMKTS)?
The most recent average sentiment score for AB SCIENCE SA (ABSCF:OTCMKTS) is 57 out of 100.
What is the most recent average sentiment for AB SCIENCE SA (ABSCF:OTCMKTS)?
The most recent sentiment for AB SCIENCE SA (ABSCF:OTCMKTS) is .
SEC-8K** Filing Available For AB SCIENCE SA (ABSCF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.